Among patients with oncogene-driven advanced NSCLC who were treated with TKIs, ctDNA clearance was associated with improved survival end points.

Chang on behalf of 361 Ohio State University Wexner Medical Center faculty and staff We, the undersigned, are OSU ...

For the remaining 7 cases, deemed extension letters were issued with the condition of producing statutory forest, environment etc. clearance letters, submitting a non-payment letter and adhering ...

The renewal of Professor Amin Alhassan’s appointment as Director-General of the Ghana Broadcasting Corporation (GBC) has drawn attention to the conditions of ...

Based on this clearance, ALX Oncology will initiate a single-agent dose-escalation and expansion Phase 1 clinical trial for ALX2004 in mid-2025. “Clinical advancement of our first ADC and the first ...

Based on this clearance, ALX Oncology will initiate a single-agent dose-escalation and expansion Phase 1 clinical trial for ALX2004 in mid-2025. “Clinical advancement of our first ADC and the ...

ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload ...